Clinical Trials Browser

Phase NA × Gene Expression Profiling × Other hematologic neoplasm × Clear all

NCT02551718 2022-06-30

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

Phase NA Completed

34 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma